DCF — MAHASKA HEALTH PARTNERSHIP
Enterprise Value: $-55.3M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-55.3M
Enterprise Value
$-19.0M
PV of Cash Flows
$-36.4M
PV of Terminal Value
$-58.6M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $77.9M | $-2.7M | -3.0% | $-6.0M | $-5.4M |
| Year 2 | $80.3M | $-1.9M | -2.0% | $-5.3M | $-4.4M |
| Year 3 | $82.7M | $-1.2M | -1.0% | $-4.7M | $-3.5M |
| Year 4 | $85.1M | $-0.8M | -1.0% | $-4.4M | $-3.0M |
| Year 5 | $87.7M | $-0.6M | -1.0% | $-4.3M | $-2.7M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-55.3M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$75.6M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.03903332363222272
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5